ViroScanner AI
Accelerating Viral Cures through Intelligent Molecular Synthesis
Company Overview
Snapshot
Founded in January 2026 by Amit Zul, ViroScanner AI operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing its core technology.
Business overview
ViroScanner AI is a Health Tech & Life Sciences company specializing in accelerating viral cures through intelligent molecular synthesis. The company offers a high-performance molecular screening platform that combines cutting-edge AI, computational chemistry, and proprietary optimization algorithms to bypass traditional R&D timelines. ViroScanner AI operates within the Pharma & Medical Biotechnology sector, specifically focusing on Drugs Discovery & Development, and targets the Healthcare & Life Sciences industry, particularly pharmaceuticals.
Company Intelligence Q&A
- When was ViroScanner AI founded?
- ViroScanner AI was founded in January 2026.
- Who is the founder of ViroScanner AI?
- Amit Zul is the founder of ViroScanner AI.
- What is ViroScanner AI's primary sector?
- ViroScanner AI's primary sector is Health Tech & Life Sciences.
- What is the current employee count for ViroScanner AI?
- ViroScanner AI currently has 1–10 employees.
- What is ViroScanner AI's current product stage?
- ViroScanner AI is currently in the R&D product stage, focusing on developing its core technology.